Jul 27, 2017 by Brian FeroldiNovavax, Inc.: Buy the Dip?Novavax's stock recently fell after the company shared a few positive updates. Is this a smart time to consider getting in?
Jul 27, 2017 by Brian Feroldi, Reuben Gregg Brewer, and Keith Noonan3 Top Dividend Aristocrats for the Long TermLooking for a few great dividend stocks to buy and hold? Here's why you should check out Sysco Corporation, PepsiCo, and McCormick.
Jul 26, 2017 by Brian Feroldi, Rich Duprey, and Demitri Kalogeropoulos3 Dividend Stocks That Should Pay You the Rest of Your LifeHere's why we think Anheuser-Busch InBev, Lowe’s, and Medtronic can shower their investors with income for decades to come.
Jul 26, 2017 by Brian FeroldiHere's Why Integra LifeSciences Holdings Corp. Is Sinking TodayShares fell after the company's second-quarter results came up short of expectations.
Jul 26, 2017 by Brian FeroldiWhy EXACT Sciences Corporation Is Rising TodayShares jump after the company reports blowout quarterly results.
Jul 26, 2017 by Brian Feroldi2 Incredibly Cheap Dividend StocksThese two dividend payers are trading on the cheap, but is either stock worth buying today?
Jul 26, 2017 by Brian Feroldi, Sean Williams, and George Budwell, PhD3 Under-the-Radar Stocks in the Healthcare SectorSyndax Pharmaceuticals, Corcept Therapeutics, and LeMaitre Vascular might not be household names, but they are companies investors should get to know.
Jul 25, 2017 by Brian FeroldiWhy Novavax, Inc Is Tanking TodayShares are plunging after the clinical-stage vaccine maker provided investors with a slew of clinical updates.
Jul 24, 2017 by Brian FeroldiHere's Why WebMD Health Corp. Is Soaring TodayShares jumped after the health information services company announced that it is being taken private.
Jul 22, 2017 by Brian FeroldiHere's How to Find the Best Dividend StocksAre you looking for a way to identify the best dividend-paying stocks? Use this simple three-step process to put your income stocks to the test.
Jul 21, 2017 by Brian FeroldiSkyworks Solutions Inc. Delivers on Its PromisesSkyworks' connectivity sales are booming and management expects the good times to continue.
Jul 21, 2017 by Brian Feroldi7 Near-Monopolies That Are Perfectly Legal in AmericaThese seven companies dominate their industries so heavily that it isn't much of a stretch to consider them virtual monopolies.
Jul 19, 2017 by Brian Feroldi10 Highest-Yielding Dividend Stocks Today: To Buy or Not to BuyS&P 500 companies with yields above 5% are rare. They can also be risky. So before you add any to your portfolio, there are a few tests worth performing.
Jul 19, 2017 by Brian Feroldi, Travis Hoium, and John Rosevear3 Stocks That Look Today Like Activision Blizzard Did in 2014NVIDIA, First Solar, and Inogen are each well positioned to offer investors multibagger gains over the next few years.
Jul 18, 2017 by Brian FeroldiHere's Why Quidel Corporation Is Rising TodayTraders cheer the news that the company is buying a handful of product lines from Alere.
Jul 18, 2017 by Brian Feroldi, Rich Duprey, and Demitri KalogeropoulosShould You Buy Into the Hype Surrounding These Stocks?The markets appear to be overly excited about Blue Apron, Activision Blizzard, and Editas Medicine right now, but should you be?
Jul 18, 2017 by Brian FeroldiThese 2 Companies Have No CompetitionNovocure and Acadia Pharmaceuticals have their niches all to themselves, and no rivals on the horizon -- a formula for profits and growth that makes their shares well worth considering.
Jul 18, 2017 by Brian Feroldi, Sean Williams, and George Budwell, PhD3 Healthcare Stocks for Ambitious InvestorsOn the hunt for a few healthcare stocks that hold a lot of upside potential? Here's why you should check out Geron Corp., Insys Therapeutics, and ViewRay.
Jul 17, 2017 by Brian FeroldiShould Mazor Robotics' Investors Fear the Incoming Competition?Mazor Robotics has a commanding lead in the robotic surgical markets for spine and brain procedures, but do investors finally need to start worrying about the competition?
Jul 17, 2017 by Brian FeroldiWhy TherapeuticsMD Inc Is Getting ClobberedShares tumble after the company failed to produce upbeat regulatory news.
